FDA Inspection 1265595 — Zhejiang Guobang Pharmaceutical Co., Ltd
The FDA completed an inspection of Zhejiang Guobang Pharmaceutical Co., Ltd on March 3, 2025 in Shaoxing. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 3, 2025
- Fiscal Year
- 2025
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Shaoxing (China)